Sign In
Buy IMMP
$0.407
-0.0093 (-2.24%)
At Close: Jun 03, 2026
New York, New York--(Newsfile Corp. - June 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of Immutep Ltd. (NASDAQ: IMMP)
Bronstein, Gewirtz & Grossman LLC Urges Immutep Limited Investors to Act: Class Action Filed Alleging Investor Harm
12:00pm, Wednesday, 03'rd Jun 2026
NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Immutep L
IMMP DEADLINE: Levi & Korsinsky Reminds Immutep Limited Investors of Upcoming Securities Class Action Deadline
09:00am, Wednesday, 03'rd Jun 2026
IMMP Investors Lost $2.28 Per Share After Immutep Allegedly Concealed Red Flags That Its TACTI-004 Trial Would Fail: What Insiders Allegedly Knew Before the 83% Collapse NEW YORK, June 3, 2026 /PRNews
Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP
04:00am, Wednesday, 03'rd Jun 2026
Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP PR Newswire
Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP
03:02am, Wednesday, 03'rd Jun 2026
LOS ANGELES, June 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Immutep Limited ("Immutep" or "the Company") (NASDAQ: IMMP) for violations of §§10(b)
New York, New York--(Newsfile Corp. - June 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of Immutep Ltd. (NASDAQ: IMMP)
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts (“ADRs”) of Immutep Ltd. (NASDAQ: IMMP) betw
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Immutep Limited (“Immutep” or the “Company”) (NASDAQ: IMMP). Such in
IMMP Shareholder Alert: Immutep Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
04:00pm, Tuesday, 02'nd Jun 2026
NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP notifies investors that Stephan Winckels, Chief Medical Officer of Immutep Limited (NASDAQ: IMMP), is named as an individual defendant in a securities
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Immutep To Contact Him Directly To Discuss Their Options If you purchased or acquired
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Immutep Limited (“Immutep” or the “Company”) (NASDAQ: IMMP) investo
IMMP Shareholder Alert: Immutep Limited Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
09:00am, Tuesday, 02'nd Jun 2026
NEW YORK, June 2, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Immutep Limited (NASDAQ: IMMP). Shareholders who purchased shares of IMMP during the class per
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm
08:20am, Tuesday, 02'nd Jun 2026
LOS ANGELES, June 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Immutep Limited (“Immutep” o
New York, New York--(Newsfile Corp. - June 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of Immutep Ltd. (NASDAQ: IMMP)
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 6, 2026 in Immutep Limited Lawsuit - IMMP
02:33pm, Monday, 01'st Jun 2026
Were Immutep's Risk Warnings Adequate? The Complaint Alleges Generic Cautionary Language Could Not Shield Defendants Who Allegedly Knew TACTI-004 Faced Specific, Undisclosed Futility Risks Were Immute
